Mashhad University of Medical Sciences, 2023-04-30: Iranian pilot trial combining ORAL methylene blue with platelet-rich plasma-fibrin glue in non-healing diabetic foot ulcers (estimated 20 participants), status 'Unknown', no results.
The aim of this study is to evaluate the chance of non-healing diabetic foot ulcers repair by improving the condition of lack of oxygen or hypoxia in the wound area caused by diabetes using methylene blue along with the use of platelet-rich plasma-fibrin glue as an effective treatment for wound healing.
Registry record field
Mashhad University of Medical Sciences, 2023-04-30: Iranian pilot trial combining ORAL methylene blue with platelet-rich plasma-fibrin glue in non-healing diabetic foot ulcers (estimated 20 participants), status 'Unknown', no results. Record field from the API v2 record. Status UNKNOWN, estimated enrolment 20, phase EARLY_PHASE1. Sponsor: Mashhad University of Medical Sciences. Route here is oral (systemic), not topical photodynamic , a different rationale (hypoxia) from the PDT trials. 'Status unknown, no results'. Study type: regulatory record.
